Novocure Ltd.

This large, completed Phase 3 trial tested whether adding a portable, battery-operated device to standard chemotherapy could help people with advanced pancreatic cancer live longer. The device, worn on the abdomen, delivers low-intensity electric fields (called TTFields) aimed at…